Iran-born anti-regime Nasdaq biotech investor says he is trying to cure ‘two cancers’ – interview

Iran-born US biotech CEO Amir Heshmatpour says his Nasdaq-listed brain cancer company will begin treating patients in Israel within weeks, as he also voices support for ending Iran’s clerical rule..   Read More in Israel NOWlej.